Skip to main content

Table 3 Ectoparasiticide doses purchased by cat owners during a 12-month period

From: Analysis of gaps in feline ectoparasiticide purchases from veterinary clinics in the United States

Doses purchased per 12 months

Fluralanera

(n = 27,138)

Fipronil /(s)-methoprene/ pyriproxyfen (n = 10,171)

Imidacloprid/pyriproxyfen (n = 3480)

Selamectin (n = 74,064)

1

18,265 (67.3%)

3609 (35.5%)

1903 (54.7%)

28,044 (37.9%)

2

5216 (19.2%)

1342 (13.2%)

467 (13.4%)

9202 (12.4%)

3

1986 (7.3%)

1846 (18.2%)

239 (6.9%)

8355 (11.3%)

4

1264 (4.7%)

963 (9.5%)

271 (7.8%)

2882 (3.9%)

5

407 (1.5%)

211 (2.1%)

67 (1.9%)

1392 (1.9%)

6

 

1045 (10.3%)

297 (8.5%)

12,160 (16.4%)

7

 

141 (1.4%)

37 (1.1%)

1584 (2.1%)

8

 

411 (4.0%)

94 (2.7%)

3118 (4.2%)

9

 

264 (2.6%)

16 (0.5%)

1595 (2.2%)

10

 

50 (0.5%)

12 (0.3%)

526 (0.7%)

11

 

38 (0.4%)

8 (0.2%)

361 (0.5%)

12

 

251 (2.5%)

 

4845 (6.5%)

  1. aBecause fluralaner topical has a 12-week dosing interval for most parasites on the product label, a maximum of 5 doses fluralaner topical purchases were considered for the 12-month period studied (Note: Up to 7 doses of fluralaner may be required for full year protection in areas where Dermacentor variabilis are of concern)